Neil Kumar

Affiliations

  • Ceo And President at Bridgebio Pharma Inc. (BBIO), 2024-03-14
  • Director at Lianbio (LIAN), 2021-11-09
  • Chief Executive Officer at Eidos Therapeutics Inc. (EIDX), 2019-07-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EIDX $29.90 882,353 Large Shareholder, Officer, Director 24,575,501 2019-07-03 Filing
EIDX $25.93 1,103,848 Large Shareholder, Officer, Director 23,693,148 2019-05-24 Filing
EIDX $13.96 2,664 Large Shareholder, Officer, Director 22,589,300 2018-12-10 Filing
EIDX $13.29 37,989 Large Shareholder, Officer, Director 22,586,636 2018-12-10 Filing
EIDX $14.36 4,860 Large Shareholder, Officer, Director 22,548,647 2018-12-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BBIO $29.55 200 Officer, Director 4,813,197 2023-11-17 Filing
BBIO $29.10 51,352 Officer, Director 4,813,397 2023-11-17 Filing
BBIO $28.59 51,552 Officer, Director 4,813,197 2023-08-17 Filing
BBIO $14.01 51,552 Officer, Director 4,813,197 2023-05-17 Filing
BBIO $14.18 120,000 Officer, Director 1,012,722 2023-05-03 Filing